ANGPT2 and non-small cell lung carcinoma: There was no significant heterogeneity (I2 = 0 %, p = 0.995), and the pooled HR was 1.93 (95 % CI: 1.47–2.52), indicating that Ang-2 expression predicted worse prognosis in NSCLC.